Skip to main content

NVS · Novartis AG · Congressional Trades

Track NVS — free
$160.50 +0.25 (+0.16%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$303.12B
Shares
1.89B
Volume · Nov 13 1.42M Avg daily vol (3M) 2.11M

Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.

Date Member Type Amount
2026-08-27 Kevin Hern Sell ST · Novartis AG Common Stock (NVS) $15K - $50K
2026-03-31 Alan Armstrong Buy Stock · Novartis AG Common Stock $1K - $15K
2026-03-30 Alan Armstrong Buy Stock · Novartis AG Common Stock $15K - $50K
2025-10-31 Lisa McClain Sell ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-10-30 Lisa McClain Sell ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-10-30 Lisa McClain Buy ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-09-25 Lisa McClain Sell ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-09-11 Lisa McClain Buy ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-07-22 Lisa McClain Sell ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-06-17 Lisa McClain Buy ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-06-11 Lisa McClain Buy ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-06-10 Lisa McClain Sell ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-06-09 Lisa McClain Buy ST · Novartis AG Common Stock (NVS) $1K - $15K
2025-03-24 George Whitesides Sell ST · Novartis AG Common Stock (NVS) $100K - $250K
2024-04-09 Sheldon Whitehouse Sell Stock · Novartis Ag ADR $1K - $15K
2023-09-20 Sheldon Whitehouse Buy Stock · Novartis Ag ADR $15K - $50K
2023-07-10 Daniel Goldman Sell ST · Novartis AG (NVS) $50K - $100K
2023-04-26 Thomas R Carper Buy Stock · Novartis AG Common Stock $1K - $15K
2023-03-31 Daniel Goldman Buy ST · Novartis AG (NVS) $50K - $100K
2023-02-27 Daniel Goldman Sell ST · Novartis AG (NVS) $15K - $50K
2023-01-31 Kevin Hern Sell ST · Novartis AG (NVS) $1K - $15K
Showing 1–21 of 21 trades
Key facts CIK 1114448 CUSIP 66987V109 13F (30d) 1276 filings 1161 filers Visit website Investor relations